Membrane deformation and layer-by-layer peeling of giant vesicles induced by the pore-forming toxin pneumolysin by Drücker, Patrick et al.
Biomaterials
Science
PAPER
Cite this: Biomater. Sci., 2019, 7,
3693
Received 25th January 2019,
Accepted 30th May 2019
DOI: 10.1039/c9bm00134d
rsc.li/biomaterials-science
Membrane deformation and layer-by-layer peeling
of giant vesicles induced by the pore-forming
toxin pneumolysin†
Patrick Drücker, *a,b Ioan Iacovache,c Simon Bachler,a Benoît Zuber, c
Eduard B. Babiychuk,b Petra S. Dittrich a and Annette Draegerb
Protein–membrane interactions that modify the shape of membranes are important for generating curva-
ture, membrane deformation by protein–protein crowding or traﬃcking of vesicles. Giant vesicles represent
a simpliﬁed but versatile model for biological membranes and are commonly employed for the study of
lipid domains and permeation across compartments. In this study, we investigated the interaction of pneu-
molysin (PLY), a pore-forming toxin secreted by Streptococcus pneumoniae, with multilamellar and unila-
mellar membranes. It reveals an enlargement of membrane area due to the insertion of pores into the
bilayer and protein–membrane aggregations that induce membrane deformation and wrinkling. Moreover,
we demonstrate that PLY peel-oﬀ layers from multilamellar giant vesicles in a hitherto unknown layer-by-
layer peeling mechanism, which reveals the structure and number of membrane lamellae. We employed
microﬂuidic methods to capture giant vesicles and confocal laser scanning microscopy, transmission
microscopy, dynamic light scattering and cryo-electron microscopy to disclose the structure of multilamel-
lar vesicles. Based on our ﬁndings we suggest how back-to-back pore arrangements stabilize large PLY–
membrane entities and that pore-displaced lipids possibly remain in the membrane.
Introduction
The interactions of pore-forming toxins (PFTs) with biological
membranes, that include membrane binding, the re-organiz-
ation during pore formation and barrier disintegration were
often investigated to analyze the mechanism of membrane per-
foration and the pathogenicity on cells.1–4 The pore-forming
toxin, pneumolysin (PLY), secreted by Streptococcus pneumo-
niae, can cause severe pneumonia or meningitis in humans.5
As a member of the cholesterol-dependent cytolysins (CDCs),
PLY is secreted as a soluble monomer, which binds to chole-
sterol in cellular membranes, self-assembles to oligomers and
forms pre-pores which eventually transform to large active
pores.5,6 These pores finally promote cell lysis and death.7
In addition to pore formation, previous studies also revealed
remarkable protein-induced structural modifications of biological
membranes, such as membrane bending by protein–protein
crowding,8,9 the rolling of supported membranes as a result of
annexin proteins causing membrane curvature10 or cytochrome c
collapsing specific domains on giant vesicles.11 Interestingly, also
membrane-active, antimicrobial peptides could promote strain-
induced membrane lysis after pore formation.12 In general, PLY
is well known for the perforation of membranes by the formation
of holes, but membrane deformation or peeling of multilamellar
membranes has not been observed nor addressed in detail.6,13–16
Furthermore, PLY has been regularly employed to investi-
gate cellular repair mechanisms,17,18 including calcium-depen-
dent plasma membrane repair,19 active microvesicle shed-
ding20 or the blebbing of cellular membranes.21 Recently, we
demonstrated that cell repair mechanisms advance from an
inhomogeneous binding of non-lytic PLY concentrations to
plasmalemmal, cholesterol-rich domains.22
In order to address PFT–membrane interactions, giant
unilamellar vesicles (GUV) are used as a model to represent bio-
logical bilayer membranes and cellular curvature.23,24 Although,
the term GUV is regularly used, exact unilamellarity is not
always assured. For instance, vesicles generated by swelling
methods may have a variable number of lamellae.25 However,
the lamellarity of membranes is important when vesicle per-
meation by PFTs or other permeation studies are investigated.
Many protein–membrane interactions, including per-
meation analysis, were recently addressed by employing the
advantages of microfluidic devices.26–28 These comprise the
ability to control incubation into sorted compartments while†Electronic supplementary information (ESI) available. See DOI: 10.1039/c9bm00134d
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immobilizing vesicles without chemical tethers. In addition
microfluidic devices are well compatible with high-resolution
fluorescence imaging techniques.29–31
Herein, we investigated protein–membrane interactions of
pneumolysin on individual multilamellar giant vesicles in a
microfluidic device and show protein–membrane aggregation
that induces membrane wrinkling and membrane surface
enlargements. These eﬀects led to an unexpected layer-by-layer
peeling, which reveals the number of lamellae of giant vesicles.
Furthermore, we discriminate between diﬀerent multilamellar
membranes and predict the number of lamellae by employing
transmission wide field microscopy without being restricted by
occasional photo bleaching during prolonged observation.32
Results
Phosphatidylcholines are the most prevalent lipids in eukary-
otic cell plasma membranes33,34 and are widely used for mem-
brane model systems such as giant vesicles.35–39 Thus, we con-
firmed binding of pneumolysin to large unilamellar vesicles
containing either unsaturated di-oleoyl-phosphatidylcholine
(DOPC) or saturated di-palmitoyl-phosphatidylcholine (DPPC)
and cholesterol for the membrane models applied herein
(Fig. 1). Binding of PLY on vesicles is demonstrated by the
inhibition of hemolysis, where liposomes are pre-incubated
with pneumolysin and then exposed to human red blood cells.
This competition binding assay measures the release of hemo-
globin from lysed erythrocytes.22,40 The membrane aﬃnity
thus depends on the accessibility of the receptor cholesterol
for PLY binding and is aﬀected by cholesterol concentration
and the lipid acyl-chain saturation (Fig. 1; Table SI 1†) as also
shown on diﬀerent, sphingomyelin containing liposomes.22 A
plausible current explanation how this accessibility might be
determined by cholesterol concentration and lipid saturation,
is illustrated in Fig. 1A. It takes into account that cholesterol
has less area per molecule in membranes at high
concentrations41,42 meaning that shielding of cholesterol by
bulky lipid head groups towards water exposure is less eﬀective
in an unsaturated lipid environment and at high cholesterol
Fig. 1 Cholesterol-dependent binding of pneumolysin to phosphatidylcholine-containing liposomes. A: Sketch illustrating the relative accessibility
of cholesterol for PLY binding in dependence of lipid saturation and cholesterol concentration. B, D: The hemolytic activity after pre-incubation of
PLY with DOPC or DPPC containing large unilamellar liposomes. C, E: The half-maximal inhibitory concentrations required to prevent hemolysis
(IC50) of DOPC or DPPC and cholesterol containing LUVs depend on the amount of cholesterol. Each curve represents the results of 3 to 5 indepen-
dent experiments, each performed in triplicate and IC50 determination is the result of nonlinear regression of dose–response curve ﬁttings to the
data in B, D. Error bars represent standard deviation (SD).
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concentration, which in turn aﬀects PLY binding. This is
demonstrated by the comparison of eﬀective half-maximal
inhibitory coeﬃcients (IC50) measured by liposome pre-seques-
tration (Fig. 1B–D). For instance, the IC50 value (1.4 ± 0.1 µM)
for PLY binding to a less ordered DOPC/Chol (50 : 50) mem-
brane is smaller than IC50 = 4.8 ± 1.4 µM for a more ordered
DPPC/Chol (50 : 50) membrane and hence indicates a higher
aﬃnity (accessibility) (Fig. 1C and E; Table SI 1†).
Protein–membrane aggregation and layer-by-layer peeling of
giant vesicles
Association of mCherry–PLY with unilamellar giant vesicles of
a homogeneous, binary lipid mixture previously showed a
homogeneous distribution during initial binding and for-
mation of active pores.22 Likewise, binding of 320 nM mCherry–
PLY to multilamellar giant vesicles (DOPC/Chol, 50 : 50) appears
to be initially homogeneous. Prolonged incubation of vesicles
trapped in a microfluidic device (Fig. SI 1†) with mCherry-PLY
for more than 30 seconds induced the formation of protein–
membrane aggregates (Fig. 2A and B). This eventually led to
PLY-induced membrane deformation and wrinkling (Fig. 2B,
blue arrow) until rupture of the outer layer occurs during con-
tinued incubation (Fig. 2B, yellow arrows). Furthermore, large
PLY–membrane aggregates and tubule-like structures were
attached to the vesicle surface (Fig. 2B, green arrows), which
expanded during continued incubation (Fig. 2B).
PLY-induced ripping of the outer membrane was accompanied
by layer-by-layer peeling (Fig. 2C, arrows; Video SI 1†). While the
outer, peeling layer wrinkled (Fig. 2B and C, blue arrows), the
newly exposed layer presented initial homogeneous PLY binding
(Fig. 2C, 00:50–01:10 min) until the cycle of membrane defor-
mation, wrinkling and layer-peeling repeats (Video SI 1†). The
rupture of layers is induced when protein–protein and protein–
membrane interactions between pores induced strain on the
bilayer that exceeds the energy barrier of membrane stability. This
is the case when membrane wrinkles were formed by protein–
membrane aggregation (Fig. 2C, blue arrows) and the relative
amount of pneumolysin on the surface reaches a threshold of at
least 50–60% fluorescence intensity (Fig. 2D).
The comparison of maximum-intensities in cross-sectional
line profiles, which were deduced from transmission bright
field microscopy, demonstrated that the number of membrane
lamellae shrinks when peeling occurs (Fig. 2E). This is
similar to methods based on contrast imaging and changes in
refractive index43 but is independent from the analysis of fluo-
rescence intensity.25 For instance, the membrane lamellarity,
i.e. the intensity in transmission microscopy was reduced after
06:29 min PLY incubation time compared to 00:45 min incu-
bation time on the same vesicle (Fig. 2E, grayscale images, line
sections and line profiles). Here, several layer-by-layer peeling
events took place in between (Video SI 1†).
In comparison to vesicles of unsaturated DOPC and chole-
sterol (50 : 50) (Fig. 2), a similar lipid composition containing
the same amount of cholesterol but saturated DPPC, showed
less intensive mCherry–PLY binding and no membrane wrink-
ling nor peeling of the outer layer even during prolonged incu-
bation time under similar conditions (Fig. SI 2†). The PLY
aﬃnity of DPPC/Chol (50 : 50) liposomes, IC50 = 4.8 ± 1.4 µM is
approximately 3.4-fold lower than the aﬃnity towards DOPC/
Chol (50 : 50), IC50 = 1.4 ± 0.1 µM liposomes (Fig. 1C and E;
Table SI 1†). Thus, the capability of PLY to deform and peel oﬀ
the membrane of a multilamellar giant vesicle correlates with
the binding activity and membrane order (Fig. 1; Fig. SI 2†).
In order to analyze whether the formation of active pores is
important for membrane aggregation and peeling, we probed
several PFTs. First, to confirm that the observed membrane
interactions are not an inherent property of mCherry-tagged
PLY, we tested wild-type PLY that showed similar protein–
membrane aggregation of Bodipy-PC labeled membranes and
could induce peeling (Fig. SI 3A†). Secondly, another CDC, lis-
teriolysin-O, also induced membrane deformation, -aggrega-
tion (Fig. SI 3B,† arrow), as well as -peeling (Video SI 2†).
In contrast, inactive PFTs showed a diﬀerent behavior. The
pneumolysin mutant EGFP-ΔA146R147-PLY (NT-PLY) binds
cholesterol, oligomerizes but cannot transform into active
pores.44 It has a similar membrane binding aﬃnity than wt-
PLY, since it prevents hemolysis by wt-PLY when being pre-incu-
bated on erythrocytes.44 Binding of 340 nM NT-PLY on DOPC/
Chol (50 : 50) giant vesicles for 32 min showed only minor mem-
brane deformations (Fig. SI 3C; Video SI 3†). These were not as
pronounced as aggregations induced by active, pore-forming
PLY within 17 min under similar conditions (Fig. 2B; Fig. SI
3A†). In addition, we compared that result with another inactive
pore-forming toxin, EGFP-NT-LYS45,46 which binds sphingomye-
lin within membranes but is unable to transform into pores.
Incubation of 322 nM EGFP-NT-LYS on vesicles that contained a
similar amount of the receptor, oleoyl-sphingomyelin (OSM)
(OSM/Chol, 50 : 50) shows coverage of the membrane surface,
but was not able to induce protein–membrane aggregation,
-wrinkling or -peeling (Fig. SI 3D, Video SI 4†). Together these
findings suggest that the capability of pore-forming toxins such
as pneumolysin, to induce large protein–membrane aggregates
and membrane wrinkling is determined by the pore-forming
activity and is distinct from simple membrane binding.
PLY-induced peeling reveals the number of membrane layers
The peeling itself was recognized by movement of the aggre-
gated membrane and when a new, initially homogeneous PLY-
binding membrane becomes exposed underneath (Fig. 2;
Fig. 3A). Permeation, demonstrated by FITC-dextran that
enters the lumen of giant vesicles occurs when the outer layer
rips apart and exposes the last underlying layer for PLY associ-
ation (Fig. 3A, red arrow; Fig. 3B), at 1:05–1:10 min incubation
time. The number of membrane lamellae is reduced during
this single peeling event, as confirmed by analysis of line pro-
files across the vesicle rim from transmission bright field
microscopy (Fig. 3B). In this case, the permeated vesicle
initially contained two layers. Additionally, the time of PLY
incubation which was required to permeate giant vesicles,
increased with the number of layers (Fig. 3C).
The number of layers that peeled oﬀ an individual giant
multilamellar vesicle was counted, when it showed several
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sequential layer-by-layer peeling events. In these cases, the
relative membrane intensities of transmission bright field
microscopy were reduced in a linear manner (Fig. SI 4A†).
Moreover, the influx of FITC-dextran into the vesicle lumen
marked the last layer. This happened rapidly if only one final
layer was exposed to PLY. In combination with the number of
Fig. 2 PLY induced protein–membrane aggregation and layer-by-layer peeling of giant vesicles. A: Sketch illustrating PLY-induced membrane
wrinkling and layer-by-layer peeling. B: A giant vesicle of DOPC/cholesterol (50 : 50) is trapped in the microﬂuidic device and incubated with
mCherry-PLY (320 nM, red). PLY binding followed membrane wrinkling and the formation of protein–membrane aggregates (blue arrow), few layer
peelings (rupture of outer layer, yellow arrows), ﬁnal large surface aggregation (image at 17:22 min), which hindered further peeling and tubule struc-
tures (green arrows). Scales = 5 µm. The grayscale micrographs are bright-ﬁeld transmission images. C: A giant vesicle (DOPC/cholesterol, 50 : 50)
showing layer-by-layer peeling events during mCherry-PLY (320 nM, red) incubation. Yellow arrows indicate the movement of the outer membrane
layer during one peeling event. The newly exposed layer shows initial homogeneous PLY binding (00:50). Scale = 10 µm. D: The relative ﬂuorescence
intensity of membrane bound mCherry-PLY during initial binding to the outer layer (black), followed by the intensity of underlying membranes (blue,
green, purple) after three subsequent peeling events of the vesicle shown in C. Red lines highlight the relative intensity when a layer tears; the outer
black layer ruptured at ≈65% intensity and revealed a new layer underneath (blue). E: Two bright-ﬁeld transmission images of the vesicle shown in C
with line proﬁles measured perpendicular to the membrane rim. The line proﬁles deduced from bright-ﬁeld transmission images denote six peeling
events starting from the initial multilamellar membrane (n) (stacked graph). Scales = 10 µm. Time = mm:ss. Images representative for n = 8.
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subsequent peeling events and knowledge of when the last
layer was exposed, the total number of lamellae on the vesicle
was revealed (Fig. 3A; Fig. SI 4A, GV-7†). Individual, sub-
sequent layer-by-layer peeling events were grouped according
to similar intensity (Fig. SI 4B†). Interestingly, the membrane
rim maximal intensities in transmission bright field
microscopy for the layers 1–9 of multilamellar giant vesicles
were distinct from each other (Fig. 3D). Thus the number of
lamellae of giant vesicles could be determined without being
compromised by disadvantages of fluorescence measure-
ments, such as photo bleaching.
Interconnection of membranes by back-to-back pore
association
Prolonged incubation of PLY on vesicles which have multiple
layers led to the formation of very large protein–membrane
wrinkles and tubules (Fig. 4A and Fig. SI 3A†) that contain per-
meated, FITC-dextran filled cavities (Fig. 4A, arrow). These
structures may grow until they exceed the size of the original
vesicle (Fig. SI 3A†). This could not be observed on unilamellar
giant vesicles, showing that enough membrane material is
required as a source (discussed below).
Fig. 3 The signal intensity of the vesicle membrane rim deduced from bright ﬁeld transmission microscopy correlates with the number of layers. A:
A two layer giant vesicle (DOPC/Chol, 50 : 50, 0.05% Bodipy-PC) shows strong protein–membrane aggregation and wrinkling in the presence of
mCherry-PLY (320 nM) (red), until the outer layer rips eventually apart (here at 01:05 min, red arrow and 01:10 min, yellow arrows). The FITC dextran
intensity (green) in the vesicle’s lumen strongly increased during this event, while the potential, last membrane layer remains stable and binds PLY
homogeneously. Scale = 5 µm. B: The relative inner FITC-dextran ﬂuorescence intensity of the vesicle shown in A, which rises when the outer layer
peels apart. The membrane rim of the bright ﬁeld transmission micrographs is less intense after the layer has peeled oﬀ (equatorial confocal
microscopy sections and line proﬁles as marked). Scale = 2 µm. C: PLY-induced FITC-dextran translocation through a giant unilamellar vesicle,
which did not peel (blue), two layer vesicles (red) with one peeling event and MLVs (black). D: The relative maximum intensity of equatorial mem-
brane line proﬁles deduced from giant vesicles in relation to the number of layers. n = 49. PLY-induced layer-by-layer peeling events of 1–7 layers of
several DOPC/cholesterol (50 : 50) vesicles were analyzed. *** P < 0.001, ** P < 0.01, n.s. = not signiﬁcant. Error bars are S.D. Time = mm:ss. Images
representative for n = 4.
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Previously, on microvesicles that have been shed from cellu-
lar membranes during plasmalemmal repair, a back-to-back
association of wild-type PLY pores interconnecting two adja-
cent bilayers was observed.20 Therefore, we analyzed pore for-
mation and back-to-back pore arrangements of mCherry–PLY
and wild-type PLY on DOPC and cholesterol-containing
membranes by transmission cryo-electron microscopy (Fig. 4B
and C). Both, PLY pores as well as PLY-pre-pores form back-to-
back arrangements that interconnect adjacent bilayers (Fig. 4).
Pores were clearly distinguished from intact bilayer fragments
(Fig. 4) and led to linkage of membranes in a close vicinity of
about 25 ± 1.1 nm distance, thus demonstrating that PLY itself
is suﬃcient to interconnect lipid membranes. These protein–
protein interactions seem to promote strain on protein–mem-
brane aggregated outer layers of multilamellar vesicles as dis-
cussed above.
Layer-by-layer peeling of multilamellar giant vesicles as
demonstrated herein indicates that multiple membrane bilayers
must be aligned together. This was confirmed on PLY free, large
multilamellar liposomes of DOPC/Chol (50 : 50) where several
layers were packed in very close vicinity (Fig. SI 5†).
Membrane enlargement by binding and perforation of
pneumolysin
During the interaction of PLY pores with membranes some
vesicles occasionally deform and collapse, showing that
PLY disintegrated the membrane structure (Fig. SI 6A,†
01:10 min). This is possibly induced by the formation of many
pores and immediate protein–membrane aggregation.
Interestingly, we also observed a significant enlargement of the
vesicle diameter. Incubation of 320 nM mCherry–PLY on a DOPC/
Chol (50 : 50) unilamellar giant vesicle led to an increase in dia-
meter from 17.3 ± 0.18 µm to 23.2 ± 0.18 µm within 40 seconds
(Fig. 5A), followed by a structural disintegration and vesicle col-
lapse (Fig. SI 6B, 07:20 min; Video SI 5†). The membrane enlarges
simultaneously with the formation of active pores (Fig. SI 6C,
Fig. 4 Pneumolysin membrane organization and back-to-back pores interconnecting DOPC and cholesterol-containing membranes. A: Large
membrane wrinkles and tubules after prolonged incubation of a giant vesicle (DOPC/cholesterol, 50 : 50 and 0.05 mol% Bodipy-PC) with mCherry-
PLY (320 nM) in the presence of 0.5 mg ml−1 FITC-dextran. Scale = 10 µm. FITC-dextran-ﬁlled cavities are formed between membrane layers
(arrow). B: Transmission electron micrographs showing back-to-back pores interconnecting two adjacent bilayers of DOPC/cholesterol (50 : 50)
(2 mM in PBS), incubated with mCherry-PLY (1 µM). Side-view and top-view representations of pores. C: Transmission electron micrographs showing
back-to-back pre-pores interconnecting two adjacent bilayers of DOPC/cholesterol (60 : 40) (2 mM in PBS), incubated with wild-type-PLY (1 µM).
Blue circle: Back-to-back pre-pore and back-to-back pore sketch. Representative images for n = 4.
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FITC-dextran influx, Video SI 6†). A similar eﬀect was also demon-
strated on vesicles, which showed several peeling events before
the enlargement took place (Video SI 1,† at approx. 07:00 min).
In addition, we performed dynamic light scattering (DLS)
experiments, that could be employed to determine the size dis-
tribution of liposomes.47,48 The hydrodynamic radius of
large unilamellar liposomes (LUVs) which had a size of Ø =
170 ± 42 nm, increased to a diameter of Ø = 975 ± 130 nm
after incubation with 500 nM PLY (Fig. 5B and C). Thus, the
hydrodynamic radius of liposomes incubated with pneumoly-
sin increased approximately 5-fold. In contrast, the hydro-
dynamic radius of similar liposomes which originally had a
size of Ø = 185 ± 53 nm, only moderately increased to a
diameter of Ø = 231 ± 61 nm after treatment with 500 nM non-
pore-forming NT-PLY (Fig. SI 7†). This suggests that pneumoly-
sin increases the size of liposomes predominantly by
membrane insertion and pore formation and probably
through aggregation via pores (Fig. 4B and C).
Fig. 5 Pneumolysin-induced enlargement of vesicle membranes. A: Enlargement of a unilamellar giant vesicle (DOPC/Chol, 50 : 50, 0.05% Bodipy-
PC) in response to mCherry-PLY (320 nM, red) incubation in the presence of 0.5 mg ml−1 FITC-dextran. The blue circle refers to the original vesicle
size before treatment. Scale = 10 µm. B: Mean size distribution of large unilamellar liposomes (DOPC/Chol, 50 : 50, 0.25 mM in PBS) (blue) and the
same liposomes incubated with 500 nM PLY after 5 min incubation (black), measured by dynamic light scattering. A Gaussian distribution was deter-
mined as shown. C: DLS correlation data of all the individual measurements which are summarized in B. D: Formation of a large membrane bleb
with an interlayer cavity on a multilamellar giant vesicle (DOPC/Chol, 60 : 40, 0.05% Bodipy-PC), in response to mCherry-PLY (320 nM, red) incu-
bation in the presence of 0.5 mg ml−1 FITC-dextran. Contrast enhanced to highlight PLY on the underlying layer. Scale = 10 µm; zoom = 5 µm.
Incubation times = mm:ss. Images representative for n = 3.
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The enlargement of the outer layer of a multilamellar
vesicle can promote the formation of a large membrane bleb
that contains an aqueous cavity between layers (Fig. 5D, yellow
arrows). This cavity eventually becomes filled by FITC-dextran
(blue arrows) due to the formation of pores on the outer mem-
brane. Here, PLY monomers diﬀused through pores on the
Fig. 6 Pneumolysin–membrane aggregation and peeling of giant vesicles. A: Pneumolysin (orange) binds the outer layer of a multilamellar vesicle,
oligomerizes and performs the transition from pre-pores to active pores (small arrows). PLY binding and pore formation leads to an aerial expansion
of the vesicles outer membrane, which results in the formation of PLY–membrane wrinkling and a cavity between membranes (blue). PLY monomers
pass through existing pores, entering the lumen between the outer and the underlying membrane. B: Membrane enlargement and wrinkling of the
outer layer promotes PLY–membrane aggregated structures that induce strain by protein–protein interactions until the outer layer rips open (1) and
layer-by-layer peeling (2), (red arrows) exposes the underlying layers for PLY attack. The diﬀusion of PLY monomers between multilamellar layers
may also eﬀect PLY binding to underlying layers and the association on the outer layer from below (3). The latter results in upside-down orientated
pores. Thus, larger PLY–membrane aggregated structures were stabilized by back-to-back pore arrangements (4) interconnecting adjacent mem-
brane undulations. C: Probable structures of multilamellar giant vesicles: stacked bilayers and two options of connected bilayers.
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outer membrane to bind the layer underneath (green arrows).
Thereby, the vesicle lumen becomes enriched with FITC-
dextran (Fig. 5D, 03:52 min) too, demonstrating that active
pores are present on both adjacent membranes. In summary,
diverse eﬀects of PLY on giant vesicles were observed, includ-
ing protein–membrane aggregation (80.4%), layer-by-layer
peeling (41.2%), vesicle collapse (25.5%) and vesicle enlarge-
ment (27.5%) (n = 51). Most of these membrane deformations
were found together. At lower concentration of mCherry–PLY
(160 nM, data not shown) these eﬀects were delayed, as for
instance the first peeling event requires incubation for about
3–4 min, which is much longer than observed with 320 nM
mCherry–PLY (Fig. 2C and A).
Discussion
Binding of pneumolysin to giant vesicles resulted in several
structural modifications such as membrane–protein aggrega-
tion, -enlargement, -deformation, -wrinkling, -peeling, and
-interconnection.
In order to understand the mechanisms that may govern
the membrane enlargements induced by PLY association, it
should be acknowledged that PLY pores occupy a large areal
fraction of solid-supported bilayers (SLB) shown by atomic
force microscopy.6 The dense arrangement of pores and pre-
pores reported therein suggests that a large fraction of lipids
must have been displaced from the SLB, which was also
observed for other PFTs such as perforin,49,50 suilysin, listerily-
sin-O and lysenin.51 Such pore-displaced lipids would remain
in the membrane or possibly re-intercalate into the vesicle
bilayer rather than forming unfavorable micelles in aqueous
solution. Moreover, some of those PFTs52–54 also increased the
surface pressure on Langmuir monolayers during insertion,
which is indicative for membrane surface area enlargements.55
The possible interactions of PLY with the lipid membrane
were summarized in a sketch (Fig. 6). These included initial
homogeneous association to cholesterol, followed by the for-
mation of open pores. Briefly, the pore-forming mechanisms5,6
encompass the membrane association of monomeric PLY, oli-
gomerization to arc6 and ring structures and the assembly to
early- and late pre-pores,6 that eventually undergo transition to
active pores (Fig. 6A). The inner diameter of pneumolysin
pores is about 26 nm wide6 and the approximate dimension of
a PLY monomer in solution is 11.8 × 4.5 × 2.4 nm.56 During
PLY binding, membrane insertion and pore formation, the
vesicle membrane surface area increased in order to maintain
a constant spacing between membrane lipids and proteins.
This eﬀect appears to be diﬀerent from membrane crowding,
which induced membrane bending by lateral pressure gener-
ated by protein collision.8,9 The probability that lipids, which
were discriminated from the interior of pores, remain in the
membrane may corroborate the formation of surplus mem-
brane area on the outer layer of multilamellar giant vesicles.
This expansion then promotes the development of an inter-
membrane lumen (Fig. 6A, blue). Upon proceeding incubation
with further PLY, membrane wrinkles appear (Fig. 6B), that
allow back-to-back pore assemblies due to protein–protein
interactions. On multilamellar membranes, this might induce
strain in the outer layer until it rips open (1) and peel oﬀ (2) to
expose underlying layers for PLY incubation. Repetition of
these processes results in layer-by-layer peeling of multilamellar
giant vesicles. Furthermore, passive diﬀusion of monomers
through pores into the inter-membrane lumen (3) also enables
PLY to bind and form pores on the next underlying membrane
layer as well as on the outer layer from the inner side, which
eventually led to the formation of backward oriented pores.
The capability of PLY pores and pre-pores to interconnect adja-
cent membranes intra-stabilizes large membrane wrinkles and
also inter-connects diﬀerent lamellae to support larger
protein–membrane-aggregated structures (4). This results in
the organization of mesh-like, interdigitating membrane
lamellae and the formation of many membrane-enclosed
lumina.
The formation of very large PLY-induced membrane wrin-
kles, which contain a lot of membrane bilayers (Fig. 4A, com-
posite) indicates that lipid molecules may have been trans-
ferred from underlying, inner layers. This transfer might be
supported by PLY-induced membrane fusion between lamellae
after the formation of back-to-back pore arrangements or may
suggest an MLV structure, where lamellae are connected to
each other. In contrast to an onion-like organization of stacked
layers, multilamellar vesicles may also have connected lamel-
lae forming a stack of folded bilayers (Fig. 6C). The lipid trans-
fer is indicated on a multilamellar vesicle that shows thinning
of its membrane during the growth of surface-associated PLY–
membrane wrinkles (Video SI 7,† arrow).
The diversity of PLY-induced alterations in the morphology
of giant vesicles is likely to be aﬀected by small alterations in
the transition of pre-pores to active pores. Pre-pores bind and
interconnect the membrane but only full pores might also dis-
place pore-enclosed lipids and hence support intense mem-
brane areal expansions.
Conclusions
In summary, we demonstrated that active pore-forming toxins
such as pneumolysin, secreted by Streptococcus pneumoniae
can deform and peel oﬀ multilamellar membranes. Membrane
interactions include protein–membrane aggregation on the
outer layer of multilamellar vesicles that causes bilayer expan-
sion and wrinkling on the surface. Back-to-back pore inter-
actions indicate that strain on the surface is induced, which
led to membrane ripping and layer-by-layer peeling.
We also showed that the layer-by-layer peeling of multila-
mellar giant vesicles could be employed to determine the
number of membrane layers. Moreover, the observed structural
modifications of membranes are rather distinct from the
toxins’ well-known capability of forming pores and might
inherit more versatile functionality to weaken the integrity of
attacked membranes. Especially, the possibility that pores can
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form on the outer layer of a multilamellar vesicle while PLY
already diﬀuses through to bind and form pores on underlying
membranes has further implications. Although having probed
artificial high concentrations of lytic PLY, this points towards
the possibility that the toxin secreted by S. pneumoniae exerts
additional eﬃcacy during a bacterial invasion on cells.
Compartments that contain cholesterol,33 such as endosomes,
the Golgi or traﬃcking vesicles might become vulnerable when
some initial pores on the plasma membrane would allow
toxins to diﬀuse into the cytosol. This could play a role during
toxin-induced cell lysis, when internal membrane repair
mechanisms17,18 were overwhelmed by high toxin loads.
Methods
Materials
1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dipalmi-
toyl-sn-glycero-3-phosphocholine (DPPC), were received from
Avanti Polar Lipids (Alabaster, AL, USA). Fluorescein isothio-
cyanate (FITC)-dextran (70 kDa), dithiothreitol (DTT),
Dulbecco’s PBS, bovine serum albumin (BSA) and cholesterol
were supplied by Sigma-Aldrich (Munich, Germany).
[1,1′-Dioctadecyl-3,3,3′,3′-tetramethylindo-carbocyanine iodide]
(DiI) was purchased from Ana Spec Inc. (Fremont, CA, USA).
Poly(vinylalcohol) (PVA, 145 kDa) was obtained from Merck
KGaA (Darmstadt, Germany) and BODIPY-PC from Thermo
Fischer Scientific (Molecular Probes) (Thermo Scientific,
Reinach, Switzerland). Human blood was from the
Interregionale Blutspende SRK (Bern, Switzerland).
Protein expression and purification
Protein expression and purification followed an established
protocol. Briefly, the constructs (pET28a-His6-mCherry-PLY,
pET28a-His6-PLY,) containing the PLY sequence of
Streptococcus pneumoniae strain D3920 and pET28a-His6-LLO
coding for listeriolysin-O, were transformed into BL21 (DE3)
pLysS competent cells (Promega, Switzerland) and expression
were induced by addition of 1 mM isopropyl β-D-1-thiogalacto-
pyranoside (IPTG) (Sigma-Aldrich) at OD = 0.6 for 3 h at 37 °C.
Cells were collected by centrifugation (3500g, 30 min, 4 °C)
and lysed using lysozyme and DNAse I (Sigma-Aldrich) fol-
lowed by 10 × 20 s sonication steps with 15 s breaks (on ice)
(BANDELIN SONOPULS UW 2070, BANDELIN Electronic
GmbH & Co. KG, Berlin, Germany). After ultracentrifugation
(70 000g, 1 h, 4 °C) the protein was purified with Protino®
Ni-NTA 1 ml columns (MACHEREY-NAGEL, Oensingen,
Switzerland) using an ÄKTAprime plus (GE Healthcare, Little
Chalfont, UK). After dialysis in PBS (MWCO 12 kDa, overnight,
4 °C, Sigma–Aldrich) bacterial endotoxin was removed by
Pierce® High-Capacity Endotoxin Removal Spin Columns
(Thermo Scientific, Rockford, IL, USA). SDS-PAGE and western
blotting (1F11 mouse anti PLY IgG, Santa Cruz Biotechnology,
Dallas, TX, USA), WesternBright™ ECL detection kit, Advansta
Inc., CA, USA confirmed protein purity (≥95%). PLY constructs
were activated in the presence of 1 mM DTT and used immedi-
ately. Similar membrane aﬃnity was probed by hemolytic
activity.22 Y221G-aerolysin-EGFP was purified as described.57
The pET28-His6-EGFP-Lys(169-297) (EGFP-NT-LYS) construct
was purchased from RIKEN (Wako, Saitama, Japan) and
EGFP-NT-LYS was purified employing a modified protocol as
described.46 Briefly, the construct was transformed into BL21
(DE3) pLysS competent cells (Promega, Switzerland); growth
was followed until OD = 0.6 at 37 °C; expression was induced
by 0.2 mM IPTG at 25 °C for 6 h. Purification was performed
as described for PLY, including endotoxin removal.
Pre-sequestration hemolytic assay
An established protocol was modified as follows.22 Briefly,
liposomes (≈90 nM–188 µM) were pre-incubated with 16 nM
mCherry–PLY in the presence of 2.5 mM DTT at RT. After
15 min pre-incubation time, the addition (1 : 1 v/v) of 2%
hRBCs initiated hemolysis. The mixture containing 1% hRBCs
and 8 nM PLY (suﬃcient for 100% lysis) was then incubated
for 30 min at 37 °C. Centrifugation and measurement of
hemolysis was performed as described20 and normalized
hemolytic data were analyzed by the nonlinear regression of
(symmetrical) sigmoidal dose–response curves with variable
Hill slope using GraphPad Prism 7 (ESI; Table SI 1†).
Preparation of liposomes and giant vesicles
Lipid stocks were handled in chloroform/methanol (1 : 1 v/v)
and mixed in a molar ratio. Liposomes were prepared by extru-
sion using a 200 nm polycarbonate membrane employing a
LiposoFast-Basic extrusion system (Avestin Europe GmbH,
Mannheim, Germany) as reported earlier.58 Giant vesicles were
prepared using a modified protocol.22,59,60 Briefly, a thin film
of poly(vinyl alcohol) (PVA) is prepared by drying 30–50 µl of a
5% (w/v) PVA solution in ultrapure water at 80 °C on a glass
slide (1 cm2). The film is dried for 5 min at 40–50 °C and the
lipid mixture was deposited until the solvent evaporated. The
film was then dried (60 min, RT, vacuum) and vesicles were
swollen in PBS pH 7.4 buﬀer at 50–60 °C for 1 h. Multilamellar
vesicles were preferentially chosen for this study.
Dynamic light scattering
Liposomes (DOPC/Chol, 50 : 50, 0.6 mM) were prepared by
extrusion, 31× through a 200 nm polycarbonate membrane
(Avanti Polar Lipids) in PBS and diluted to 0.25 mM. PLY was
activated in the presence of DTT and incubated with 0.25 mM
DOPC/Chol (50 : 50) liposomes for 5 min at RT. Dynamic light
scattering was measured at 25 °C (Zetasizer Nano ZSP, Malvern
Panalytical Ltd, Malvern, UK) and data were analyzed
(Zetasizer Software 7.11) before a mean of 5 experiments is
used to calculate a Gaussian distribution (R2 = 0.98–0.99).
Buﬀers have been filtrated (pore Ø = 0.2 µm) and degassed.
Errors = S.D.
Microfluidic experiments using giant vesicles
An established microfluidic chip design29 was modified to
increase the probability of vesicle immobilization as
described.22 The device is actuated using nitrogen at a
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pressure of 200 kPa employing a custom-made pressure valve
control instrument.22 Chip fabrication followed an established
protocol as described.22,29,61 Compounds were injected using a
syringe-pump system (NanoJet syringe pump, Chemyx,
Staﬀord, TX, USA) and Teflon tubes. Ultrapure water was
added to the fluid layer and pressure control openings before
operation by centrifugation (700g, 5 min, RT) to circumvent air
pockets.29,61 The device was mounted onto the microscope
stage holder (equilibrated to T = 28 °C) and channels were
coated by 4% (w/v) BSA in PBS at a flow of 10 µl min−1 for
10 minutes. Giant vesicles were then trapped from PBS solu-
tion at 2 µl min−1 and experiments were performed at a flow
rate of 0.125 µl min−1 per chamber. This did not apply any
observable shear stress on the liposomes30 and did not aﬀect
large PLY–membrane aggregated structures.
Microscopy
The microfluidic devices were mounted on the stage of a
microscope (Zeiss LSM 880), equipped with a temperature-con-
trolled incubation chamber and a Plan APO 63×/1.4 Oil DIC
M27 objective (Carl Zeiss Microscopy GmbH, Jena, Germany).
For the excitation of mCherry or DiI, a 561 nm diode pumped
solid state (DPSS) laser (BP 578 nm–696 nm) was employed.
For FITC or EGFP, the 488 nm line of the argon laser (BP
493 nm–556 nm) and the beamsplitter MBS 488/561 were
used. Image processing included the Zeiss ZEN 2 software
(Carl Zeiss Microscopy GmbH 1997–2014) and Fiji.
Fluorescence images have been contrast enhanced to optimize
presentation (equatorial section, if not otherwise stated).
Experiments were performed at T = 28 ± 1 °C.
Cryo-transmission electron microscopy
Liposomes have been prepared in PBS (2 mM) by extrusion
using a 200 nm polycarbonate membrane employing a
LiposoFast-Basic extrusion system (Avestin Europe GmbH,
Mannheim, Germany) or by sonication, 3 pulses at30 s
(BANDELIN Sonopuls UW 2070, BANDELIN Electronic GmbH
& Co. KG, Berlin, Germany) and were mixed with 1 µM PLY in
the presence of 2 mM DTT in PBS and incubated 10 min at
37 °C. Subsequently, 3 µl of the mixtures were applied to a 2/1
quantifoil grid (Quantifoil Microtools GmbH) after 15″15 mA
glow discharging. The grids were then plunge-frozen using a
Vitrobot (FEI – Thermo Fisher) employing 2 to 5 s blotting
time, 100% humidity, 2 s wait step and 2 s drain times,
respectively. The cryo grids were imaged on an F20 microscope
(FEI – Thermo Fischer) equipped with a Falcon III direct
detector. Images were acquired in the nanoprobe mode with
total doses ranging from 30 e− Å−1 to 90 e− Å−1.
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